Diabetes

A recent retrospective analysis showed that nearly 75% of long-term care patients with diabetes received SSI.

Increasing eosinophils led to normal perivascular adipose tissue function.

Top articles of the week from The American Journal of Pharmacy Benefits.

Heart failure and frequent hospitalization can increase risk of readmission among diabetes patients.

Patients with obesity developed heart disease 4.3 years earlier.

Epalrestat could prevent metastasis in patients with basal-like triple-negative breast cancer.

Repurposed drugs may provide new therapies for cancer.

Children born to mothers with gestational diabetes have altered fat cells.

Pharmacists play an important role in helping to deal with clinical inertia.

There are several new options coming down the pipeline for patients with type 2 diabetes.

Continuing education remains an important part of a pharmacist's life, particularly those dealing with an ever-increasing population of patients with diabetes.

There are several new treatments in the pipeline that hold promise for patients with type 2 diabetes.

Sessions focuses on new diabetes treatment options.

Two new fixed-dose basal/GLP-1 receptor-agonist agents, Soliqua 100/33 (Sanofi) and Xultophy 100/3.6 (Novo Nordisk), were approved by the FDA in November 2016.

Increasing expression of REV-ERB observed to decrease LDL cholesterol.

Real-world evidence suggests SGLT-2 can reduce all-cause mortality in diabetes patients.

Increased screen time observed to be associated with adiposity.

Health applications may help younger patients successfully manage type 1 diabetes.

Limiting carbohydrate intake could improve glycated hemoglobin levels.

Study links anti-tumor immunity to islet autoimmunity.

Top news of the day from across the health care landscape.

Association found between limited gluten intake and type 2 diabetes.

Patients with diabetes in middle age were 77% more likely to develop dementia.

Top news of the day from across the health care landscape.

A lack of IRS-1 expression observed to increase cell proliferation in blood vessels of the heart.